Potato Sustainability Alliance approves third-party verification

Feb 06, 2026

The Potato Sustainability Alliance(PSA) has approved the implementation of a third-party verification process for the PSA Program, marking an important step forward in strengthening the program’s integrity, credibility, and long-term value for growers and the broader potato industry.

“Verification reinforces the credibility of the PSA Program while staying true to our grower-focused approach,” said John Mesko, CEO of the Potato Sustainability Alliance. “This step demonstrates our commitment to continuous improvement and to providing credible, reliable data that reflects what growers are doing in the field.”

Third-party verification will focus on reviewing on-farm assessment responses for accuracy and alignment with reported practices. A small, randomly selected group of farms that submitted a 2025 PSA on-farm assessment will be chosen to participate. Participation is not an audit and does not result in a pass/fail grade. Reviews are designed to be collaborative and educational, supporting program improvement. PSA fully covers all verification costs with these selected farms.

Source : The Grower

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.